Search Results - "Issa, Issa Ismail"

  • Showing 1 - 7 results of 7
Refine Results
  1. 1

    Case Series: Clinical Significance of Heterozygous Pathogenic RTEL1 Variants Identified via Routine Clinical Genetic Diagnostics.

    Authors: Wedge, Eileen Rasmussen, Andreas Ørslev Borgwardt, Line et al.

    Source: American Journal of Medical Genetics. Part A; Apr2026, Vol. 200 Issue 4, p959-965, 7p

    Save to List
  2. 2

    CRISPR-Cas9 Knockout Screens Identify DNA Damage Response Pathways and BTK as Essential for Cisplatin Response in Diffuse Large B-Cell Lymphoma.

    Authors: Issa, Issa Ismail Due, Hanne Brøndum, Rasmus Froberg et al.

    Source: Cancers. Jul2024, Vol. 16 Issue 13, p2437. 17p.

    PDF Full Text
    Save to List
  3. 3

    Overexpression of CDCA2 in Diffuse Large B-Cell Lymphoma Promotes Cell Proliferation and Bortezomib Sensitivity.

    Authors: Due, Hanne Brogaard, Asta Issa, Issa Ismail et al.

    Source: International Journal of Molecular Sciences. Jun2025, Vol. 26 Issue 12, p5596. 14p.

    HTML Full Text PDF Full Text
    Save to List
  4. 4

    Hsp90 inhibition sensitizes DLBCL cells to cisplatin.

    Authors: Schmidt, Linnéa Issa, Issa Ismail Haraldsdóttir, Hulda et al.

    Source: Cancer Chemotherapy & Pharmacology. Apr2022, Vol. 89 Issue 4, p431-440. 10p.

    HTML Full Text PDF Full Text
    Save to List
  5. 5

    Exploring the Functional Impact of Individual DDX41 Variants With a Fast and Robust Cell-Based Method.

    Authors: Nitschke NJ Almosailleakh M Issa II et al.

    Source: Human mutation [Hum Mutat] 2026 Jun 25; Vol. 2026, pp. 3758915. Date of Electronic Publication: 2026 Jun 25 (Print Publication: 2026).

    Publication Type: Journal Article

    Journal Info: Publisher: Wiley-Liss Country of Publication: United States NLM ID: 9215429 Publication Model: eCollection Cited Medium: Internet ISSN: 1098-1004 (Electronic) Linking ISSN: 10597794 NLM ISO Abbreviation: Hum Mutat Subsets: MEDLINE

    Save to List
  6. 6

    High-grade B-cell lymphoma not otherwise specified, with diffuse large B-cell lymphoma gene expression signatures: Genomic analysis and potential therapeutics.

    Authors: Lone W Bouska A Herek TA et al.

    Source: American journal of hematology [Am J Hematol] 2025 Jan; Vol. 100 (1), pp. 10-22. Date of Electronic Publication: 2024 Nov 16.

    Publication Type: Journal Article

    Journal Info: Publisher: Wiley-Blackwell Country of Publication: United States NLM ID: 7610369 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1096-8652 (Electronic) Linking ISSN: 03618609 NLM ISO Abbreviation: Am J Hematol Subsets: MEDLINE

    HTML Full Text PDF Full Text
    Save to List
  7. 7

    A bendamustine resistance gene signature in diffuse large B-cell lymphoma and multiple myeloma.

    Authors: Issa II Brøndum RF Due H et al.

    Source: Cancer drug resistance (Alhambra, Calif.) [Cancer Drug Resist] 2021 Mar 19; Vol. 4 (1), pp. 208-222. Date of Electronic Publication: 2021 Mar 19 (Print Publication: 2021).

    Publication Type: Journal Article

    Journal Info: Publisher: OAE Publishing Inc Country of Publication: United States NLM ID: 101738710 Publication Model: eCollection Cited Medium: Internet ISSN: 2578-532X (Electronic) Linking ISSN: 2578532X NLM ISO Abbreviation: Cancer Drug Resist Subsets: PubMed not MEDLINE

    Save to List

Search Tools: